WHO Adds Ozempic and Mounjaro to Essential Medicines List The World Health Organization (WHO) has taken a significant step in expanding global access to essential medicines by adding GLP-1 drugs to its prestigious list. This move comes as a part of WHO’s ongoing efforts to ensure that life-saving medications are available to all individuals worldwide, […]
Novo Nordisk’s “Super Ozempic” Trial Disappoints Again
Novo Nordisk’s “Super Ozempic” Trial Disappoints Again Novo Nordisk, a pharmaceutical giant known for its groundbreaking diabetes treatments, recently faced a setback with its highly anticipated next-generation drug, CagriSema. The company’s shares took a hit after the release of disappointing trial results that revealed CagriSema failed to outperform its competitor, Eli Lilly’s Mounjaro. The pharmaceutical […]